Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study

BACKGROUND: Triplet chemotherapy, with docetaxel-5FU-oxaliplatin (TEFOX), has yielded promising results in patients with advanced and operable gastric adenocarcinoma. This may prove useful in treating signet ring cell carcinoma (SRCC), which is known to be chemoresistant and has a poor prognosis. We...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Br J Cancer
Hoofdauteurs: Pernot, Simon, Dubreuil, Olivier, Aparicio, Thomas, Le Malicot, Karine, Tougeron, David, Lepère, Céline, Lecaille, Cedric, Marthey, Lysiane, Palle, Juliette, Bachet, Jean-Baptiste, Zaanan, Aziz, Taieb, Julien
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group UK 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6133962/
https://ncbi.nlm.nih.gov/pubmed/29872148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0133-7
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items